v3.26.1
SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS (Details Narrative)
3 Months Ended 6 Months Ended
Apr. 17, 2026
USD ($)
Apr. 16, 2026
USD ($)
$ / shares
shares
Jan. 28, 2026
USD ($)
Jan. 27, 2026
USD ($)
$ / shares
shares
Apr. 09, 2025
USD ($)
Jun. 30, 2026
USD ($)
$ / shares
shares
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
shares
Jun. 30, 2026
USD ($)
$ / shares
shares
Jun. 30, 2025
USD ($)
shares
Jun. 09, 2026
USD ($)
Feb. 06, 2026
USD ($)
Subsidiary, Sale of Stock [Line Items]                        
Aggregate offering price value               $ 4,244,467        
Issuance of common shares for cash, net of offering costs                 $ 1,291,038 $ 578,499    
Legal fees       $ 35,000                
Clearing agent fee       $ 10,000                
Fair value of warrant                 (858)    
Legal and other offering-related fees $ 591,085   $ 305,990                  
Nominal exercise price | $ / shares           $ 0.0001     $ 0.0001      
Proceeds from exercise                 $ 1,523,242 $ 75,044    
Issuance of restricted stock awards | shares                 7,052 466    
Restricted stock grant-date fair value                      
Share-Based Payment Arrangement, Option [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Stock based compensation expenses             $ 414   $ 276 $ 828    
Restricted Stock [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Stock based compensation expenses           $ 17,438 0   $ 17,438 0    
Issuance of restricted stock awards | shares                 92,590      
Restricted stock grant-date fair value                 $ 209,253      
Unamortized stock-based compensation costs           191,816     $ 191,816      
Weighted average period                 10 months 24 days      
Restricted Stock Units (RSUs) [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Stock based compensation expenses           107,676 $ 205,846   $ 196,073 $ 399,280    
Unamortized stock-based compensation costs           $ 1,741,914     $ 1,741,914      
Weighted average period                 3 years 1 month 28 days      
Common stock vested restricted stock units | shares                 5,886      
Common Stock [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Aggregate offering price value               $ 1,024        
Issuance of common shares for cash, net of offering costs, shares | shares               102,444        
Exercise of warrants, shares | shares           1,950,349   38,528        
Issuance of restricted stock awards | shares               1,215        
Restricted stock grant-date fair value               $ 12        
Common Stock [Member] | Restricted Stock Units (RSUs) [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Common stock vested restricted stock units | shares                 7,435      
Measurement Input, Risk Free Interest Rate [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Warrants and rights outstanding, measurement input 3.9   3.8                  
Measurement Input, Expected Term [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Expected term 5 years 1 month 13 days   5 years                  
Measurement Input, Option Volatility [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Warrants and rights outstanding, measurement input 116.0   116.0                  
Measurement Input, Expected Dividend Payment [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Warrants and rights outstanding, measurement input 0   0                  
Series G Warrant [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Exercise of warrants, shares | shares           143,380            
Proceeds from exercise           $ 596,461,000,000            
Series H Warrant [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Exercise of warrants, shares | shares           222,746            
Proceeds from exercise           $ 926,623,000,000            
Placement Agent Warrants [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Exercise price | $ / shares       $ 5.5125                
Percentage of placement agent cash fees gross proceeds       7.00%                
Management fee percentage       1.00%                
Warrants issued | shares       23,016                
Public offering price percentage   125.00%   125.00%                
Fair value of warrant $ 223,000   $ 63,000                  
Pre-Funded Warrants [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Exercise of warrants, shares | shares           1,584,223            
Proceeds from exercise           $ 158            
Private Placement [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Exercise price | $ / shares       $ 4.16                
Private Placement [Member] | Series G Warrant [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Warrants issued | shares       328,802                
Private Placement [Member] | Series H Warrant [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Warrants issued | shares       328,802                
ATM Agreement [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Aggregate offering price value         $ 1,854,151              
Percentage of gross sales price         $ 3              
Arrangement registration payment                     $ 2,425,000 $ 1,346,000
Issuance of common shares for cash, net of offering costs, shares | shares                 497,200      
Issuance of common shares for cash, net of offering costs                 $ 1,291,038      
Remaining amount available to sell           $ 2,425,000     $ 2,425,000      
January 2026 Purchase Agreement [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of shares issued | shares       328,802                
Number of shares sold, per shares | $ / shares       $ 4.41                
Aggregate gross proceeds from offering       $ 1,500,000                
Securities Purchase Agreement [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Aggregate gross proceeds from offering   $ 5,000,000.0                    
Securities Purchase Agreement [Member] | Common Stock [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of shares issued | shares   98,000                    
Securities Purchase Agreement [Member] | Pre-Funded Warrants [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of shares issued | shares   2,124,223                    
Securities Purchase Agreement [Member] | Series I Warrants [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of shares issued | shares   2,222,223                    
Expected term   5 years                    
Securities Purchase Agreement [Member] | Series J Warrants [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of shares issued | shares   2,222,223                    
Exercise price | $ / shares   $ 2.00                    
Expected term   18 months                    
Nominal exercise price | $ / shares   $ 0.0001                    
April Placement Agent Warrants [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of shares issued | shares   155,556                    
Percentage of placement agent cash fees gross proceeds   7.00%                    
Management fee percentage   1.00%                    
April Placement Agent Warrants [Member] | Series I Warrants [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Exercise price | $ / shares   $ 2.8125